UBS Group’s Kronos Bio KRON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,012
| Closed | -$1.91K | – | 9082 |
|
|
2024
Q4 | $1.91K | Buy |
+2,012
| New | +$1.91K | ﹤0.01% | 7897 |
|
|
2024
Q2 | – | Sell |
-20,645
| Closed | -$26.8K | – | 8579 |
|
|
2024
Q1 | $26.8K | Buy |
+20,645
| New | +$26.8K | ﹤0.01% | 5613 |
|
|
2023
Q4 | – | Sell |
-100
| Closed | -$130 | – | 8336 |
|
|
2023
Q3 | $130 | Buy |
+100
| New | +$130 | ﹤0.01% | 7676 |
|
|
2023
Q2 | – | Sell |
-15,091
| Closed | -$22K | – | 8132 |
|
|
2023
Q1 | $22K | Buy |
15,091
+4,166
| +38% | +$6.08K | ﹤0.01% | 5920 |
|
|
2022
Q4 | $17.7K | Buy |
10,925
+10,891
| +32,032% | +$17.6K | ﹤0.01% | 6624 |
|
|
2022
Q3 | $0 | Buy |
+34
| New | – | ﹤0.01% | 9459 |
|
|
2022
Q2 | – | Sell |
-93,236
| Closed | -$674K | – | 9499 |
|
|
2022
Q1 | $674K | Buy |
93,236
+46,940
| +101% | +$339K | ﹤0.01% | 3550 |
|
|
2021
Q4 | $629K | Buy |
46,296
+44,000
| +1,916% | +$598K | ﹤0.01% | 3805 |
|
|
2021
Q3 | $48K | Buy |
2,296
+200
| +10% | +$4.18K | ﹤0.01% | 5267 |
|
|
2021
Q2 | $50K | Buy |
2,096
+93
| +5% | +$2.22K | ﹤0.01% | 5368 |
|
|
2021
Q1 | $59K | Sell |
2,003
-302
| -13% | -$8.9K | ﹤0.01% | 5375 |
|
|
2020
Q4 | $69K | Buy |
+2,305
| New | +$69K | ﹤0.01% | 4940 |
|